(Louis) Sarah, Plain And Tall (Large Print)
by American Printing House for the Blind
Last verified June 15, 2026 · classified June 15, 2026
What it is
Summary
AI-generated from vendor-published content · June 15, 2026
This is a large-print edition of Patricia MacLachlan's classic children's novel *Sarah, Plain and Tall*, produced by the American Printing House for the Blind specifically for readers with low vision. The text is formatted with enlarged typeface and high contrast to reduce eye strain and support independent reading for people who can't comfortably access standard print. It's part of APH's Louis catalog, which indexes accessible books for students and adults with visual impairments. This is a complete, standalone book — no device or software required. Federal Quota funds are available, meaning it can be obtained through a state's quota allocation for students with visual impairments at no direct cost to qualifying schools or families.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- School district
What Setup Looks Like
- Out of the box
- Open and read — no setup, charging, or pairing required.
- Confirm font size is appropriate for the reader's current vision before purchasing, as large-print sizing varies by publisher.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
Wondering how equipment like this gets paid for? See the official funding programs in your state.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from American Printing House for the Blind — view on vendor site; last verified June 15, 2026.
Classification & description AI-generated from vendor-published content on June 15, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.